Occupational risk and the development of premalignant skin lesions among paraquat manufacturers
- PMID: 3493801
- PMCID: PMC1007804
- DOI: 10.1136/oem.44.3.196
Occupational risk and the development of premalignant skin lesions among paraquat manufacturers
Abstract
The objective of this study was to determine the prevalence rate and possible aetiological factors of premalignant skin lesions observed among paraquat manufacturers. A total of 228 workers in 28 factories were interviewed and independently examined by a dermatologist during site inspection in 1985. Information concerning past working experience, current toxic exposures, other risk factors of hyperpigmented macules and keratosis, and the past and present manufacturing processes of each factory was collected. Sixty nine cases of hyperpigmented macules and 17 of hyperkeratosis were found. Typical macules were irregular in shape, pin head size, hyperpigmented, with or without hyperkeratosis, and usually distributed symmetrically over the forearms, hands, neck, and upper chest, where exposure to sunlight was maximal. Six patients with hyperkeratotic lesions subsequently had biopsies performed and two showed Bowenoid changes. Eighty per cent (28 cases) and 67% (38 cases) of workers developed hyperpigmented macules if they had ever been engaged in bipyridine centrifugation and crystallisation, respectively; there were three workers 3% with such lesions among those who performed packaging or administrative jobs, or both. There was a significant trend (p less than 0.0001) for workers to develop hyperpigmented macules and hyperkeratosis the longer they had been exposed to centrifugation or crystallisation, or both, independent of age and the duration of exposure to sunlight. Evidence is presented to suggest that sunlight is a necessary cofactor and that the aetiological agent was produced during high temperature sodium process of bipyridine synthesis, and possibly bipyridine isomer(s).
Similar articles
-
Photodamage and skin cancer among paraquat workers.Int J Dermatol. 1995 Jul;34(7):466-9. doi: 10.1111/j.1365-4362.1995.tb00611.x. Int J Dermatol. 1995. PMID: 7591408
-
Occupationally related tumors in tar refinery workers.J Am Acad Dermatol. 1998 Nov;39(5 Pt 1):712-20. doi: 10.1016/s0190-9622(98)70043-x. J Am Acad Dermatol. 1998. PMID: 9810887
-
Premalignant and neoplastic skin lesions associated with occupational exposure to "tarry" byproducts during manufacture of 4,4'-bipyridyl.Br J Ind Med. 1982 Feb;39(1):76-81. doi: 10.1136/oem.39.1.76. Br J Ind Med. 1982. PMID: 7066224 Free PMC article.
-
Paraquat in developing countries.Int J Occup Environ Health. 2001 Oct-Dec;7(4):275-86. doi: 10.1179/107735201800339209. Int J Occup Environ Health. 2001. PMID: 11783857 Review.
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
Cited by
-
Blockade by 2,2',2''-tripyridine of the nicotinic acetylcholine receptor channels in embryonic Xenopus muscle cells.Br J Pharmacol. 1993 Sep;110(1):163-8. doi: 10.1111/j.1476-5381.1993.tb13787.x. Br J Pharmacol. 1993. PMID: 7693275 Free PMC article.
-
Increased oxidative stress and antioxidant expression in mouse keratinocytes following exposure to paraquat.Toxicol Appl Pharmacol. 2008 Sep 15;231(3):384-92. doi: 10.1016/j.taap.2008.05.014. Epub 2008 May 29. Toxicol Appl Pharmacol. 2008. PMID: 18620719 Free PMC article.
-
Cancer incidence among paraquat exposed applicators in the agricultural health study: prospective cohort study.Int J Occup Environ Health. 2009 Jul-Sep;15(3):274-81. doi: 10.1179/oeh.2009.15.3.274. Int J Occup Environ Health. 2009. PMID: 19650582 Free PMC article.
-
Studies on curare-like action of 2,2',2''-tripyridine in the mouse phrenic nerve-diaphragm.Br J Pharmacol. 1992 May;106(1):55-60. doi: 10.1111/j.1476-5381.1992.tb14292.x. Br J Pharmacol. 1992. PMID: 1504731 Free PMC article.
-
Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen's Disease and Squamous Cell Carcinoma: A Proposal.Dermatol Ther (Heidelb). 2022 Feb;12(2):361-380. doi: 10.1007/s13555-021-00644-3. Epub 2022 Feb 3. Dermatol Ther (Heidelb). 2022. PMID: 35112326 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous